|
Title
|
|
|
|
Phase
|
|
|
|
Protocol
IDs
|
|
|
|
Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
|
|
|
|
Phase III
|
|
|
|
GPOH-HIT-GBM-D
EU-205100, NCT00278278
|
|
|
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
|
|
|
|
Phase III
|
|
|
|
CHLA-HEAD-START-III
CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
|
|
|
SCRT Vs Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumours
|
|
|
|
Phase III
|
|
|
|
SCRT Trial
NCT00517959
|
|
|
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
SJCRH-SJHG04
GENENTECH-OSI3160s, NCT00124657
|
|
|
A Phase I/II Study of the Photon Radiosurgery System
|
|
|
|
Phase II, Phase I
|
|
|
|
CNS 0201
NCT00179907
|
|
|
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
|
|
|
A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
SUN08-01
NCT00704054
|
|
|
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
CHNMC-07053
07053, CA180 121, NCT00788125
|
|
|
Antineoplaston Therapy in Treating Children With Brain Tumors
|
|
|
|
Phase II
|
|
|
|
BC-BT-10
NCT00003458
|
|
|
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
|
|
|
|
Phase II
|
|
|
|
BC-BT-13
NCT00003468
|
|